Product information and disease descriptionProduct descriptionProduct information
Generic, brand name and therapeutic class of product
5 evidence topics · 9 sources
Manufacturer: Viking Therapeutics
Nonproprietary name
No evidence found.
Therapeutic class: dual GLP-1 and GIP receptor agonist
“This study aimed to determine doses of VK2735, a novel glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide (GLP‐1/GIP) receptor dual agonist, that are effective for weight loss over 13 weeks of treatment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Chemical class: peptide with a half-life-extending side chain
Chemical structure, molecular formula, and molecular weight
No evidence found.